Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Atricure, Inc. (ATRC) Tops Q2 EPS by 3c, Boosts FY Revenue Guidance

AtriCure Reports Second Quarter 2015 Financial Results and Updates 2015 Outlook

July 28, 2015 4:02 PM EDT

Revenue of $32.6 million up 22.9% as reported, 26.5% constant currency U.S. sales of $25.7 million up 29.3% International sales of $6.8 million up 3.5% as reported, 17.9% constant currency

WEST CHESTER, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in technologies for the surgical treatment of atrial fibrillation and left atrial appendage management, today announced second quarter 2015 financial results.

We are pleased by our results this quarter which reflect continued stability in our business and the solid foundation AtriCure is building for future growth, said... More